CBO
Biosimilars Landscape and FDA Regulatory Expectations
March 21 by James HarrisThe Congressional Budget Office (CBO) has estimated that the United States could save $25 billion from the use of biosimilars over 10 years. In a general sense the term biosimilars refers to fo...